SF
SFES.US Safeguard Scientifics Inc
- Market cap
- USD 10.0M
- P/E
- -
- P/B
- 0.76x
- ROE
- -88.4%
- Dividend yield
- 57.99%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Dec 2023.
Is SFES.US undervalued?
Graham numberThe Graham number of Safeguard Scientifics Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Safeguard Scientifics Inc fundamental analysis
No fundamental analysis for Safeguard Scientifics Inc yet.
Safeguard Scientifics Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Safeguard Scientifics Inc
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. …
Full company profileSafeguard Scientifics Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 1 quarter up to Dec 31, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Safeguard Scientifics Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | - | -9.47M | -7.15M | -4.78M | -5.68M | -8.00M |
| EBITDA | - | - | -6.92M | -4.50M | -5.36M | - |
| Net Income | - | -37.6M | 27.0M | -14.3M | -9.83M | -17.7M |
| EPS | - | -1.80 | 1.64 | -0.89 | -0.59 | -1.06 |
| Balance Sheet | ||||||
| Total Assets | - | 69.0M | 54.0M | 37.7M | 22.8M | 22.8M |
| Total Liabilities | - | 6.16M | 3.46M | 3.12M | 2.86M | 2.86M |
| Shareholders' Equity | - | 62.9M | 50.6M | 34.6M | 20.0M | 20.0M |
| Cash & Short-term Investments | - | 15.6M | 24.7M | 13.3M | 9.50M | 9.50M |
| Cash Flow | ||||||
| Operating Cash Flow | - | -8.14M | -8.15M | -3.26M | -3.31M | -3.27M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | -8.14M | -8.15M | -3.26M | -3.31M | -3.27M |
| Ratios | ||||||
| ROE | - | -59.8% | 53.4% | -41.3% | -49.2% | -88.4% |
| ROA | - | -54.5% | 50.0% | -37.8% | -43.0% | -77.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
Safeguard Scientifics Inc dividends
- Dividend yield
- 57.99%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 21, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2023 | USD 5.82M | 0.35 | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 20.7M | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:6 on Aug 27, 2009.
Who owns Safeguard Scientifics Inc
Ownership data of Safeguard Scientifics Inc is not available yet.
Safeguard Scientifics Inc company profile
- Company name
- Safeguard Scientifics Inc
- Ticker
- SFES.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Asset Management
- Fiscal year end
- September
- Address
- 150 North Radnor Chester Road, Radnor, PA, United States, 19087
- Phone
- 610 293 0600
- Website
- safeguardscientifics.com
About Safeguard Scientifics Inc
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Sa
Safeguard Scientifics Inc management
4- Mr. Mark R. DowCEO, CFO & Company Secretary · born 1967
- Mr. G. Matthew BarnardGeneral Counsel, Secretary & Compliance Officer
- Ms. Alex A. FuiksAssociate
- Mr. Seth ZuckermanSenior Associate of Healthcare